The efficacy and prognosis analysis of rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone regimen in the treatment of primary non-Hodgkin lymphoma of bone

YANG Yi; GUO Wei

doi:10.3969/j.issn.2095-252X.2012.04.007

Home>Articles>The efficacy and prognosis analysis of rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone regimen in the treatment of primary non-Hodgkin lymphoma of bone

DOI: 10.3969/j.issn.2095-252X.2012.04.007

The efficacy and prognosis analysis of rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone regimen in the treatment of primary non-Hodgkin lymphoma of bone

YANG Yi

GUO Wei

Machine-generated Keywords：

Publication Date：2012-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 358-361 )

CHINESE JOURNAL OF BONE AND JOINT

ISTIC

ISSN：2095-252X

Year, Vol.(Issue)：2012,1(4)